Get the Stockscreener App
1.45
0.00%
0.00
Biorestorative Therapies Inc stock is traded at $1.45, with a volume of 43,017.
It is up +0.00% in the last 24 hours and down -21.20% over the past month.
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
See More
Previous Close:
$1.45
Open:
$1.46
24h Volume:
43,017
Relative Volume:
0.55
Market Cap:
$11.57M
Revenue:
$149.50K
Net Income/Loss:
$-6.96M
P/E Ratio:
-1.0662
EPS:
-1.36
Net Cash Flow:
$-6.37M
1W Performance:
+0.00%
1M Performance:
-21.20%
6M Performance:
-18.54%
1Y Performance:
-16.67%
1-Day Range:
$1.395
$1.46
1-Week Range:
$1.39
$1.4875
52-Week Range:
$1.21
$2.55
Biorestorative Therapies Inc Stock (BRTX) Company Profile
Name
Biorestorative Therapies Inc
Sector
Industry
Phone
(631) 760-8100
Address
40 MARCUS DRIVE, MELVILLE
Compare BRTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
1.45 | 11.57M | 149.50K | -6.96M | -6.37M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Biorestorative Therapies Inc Stock (BRTX) Latest News
Can BioRestorative Therapies Inc. (9OF) stock deliver strong annual returnsTrade Entry Report & AI Forecasted Stock Moves - newser.com
Chart based exit strategy for BioRestorative Therapies Inc.July 2025 Chart Watch & High Accuracy Investment Entry Signals - newser.com
What to expect from BioRestorative Therapies Inc. in the next 30 daysQuarterly Earnings Report & Verified Trade Idea Suggestions - newser.com
Is BioRestorative Therapies Inc. (9OF) stock a defensive play amid uncertaintyIndex Update & AI Enhanced Trading Alerts - newser.com
How supply chain issues affect BioRestorative Therapies Inc. stockPortfolio Gains Report & Step-by-Step Trade Execution Guides - newser.com
Published on: 2025-09-30 03:17:26 - newser.com
Does BioRestorative Therapies Inc. stock trade at a discount to peersJuly 2025 Institutional & Real-Time Stock Movement Alerts - newser.com
Is BioRestorative Therapies Inc. stock a top momentum playMarket Movement Recap & Fast Entry and Exit Trade Plans - newser.com
Published on: 2025-09-30 01:56:19 - newser.com
Published on: 2025-09-30 01:11:57 - newser.com
What drives BioRestorative Therapies Inc stock priceReal Estate Investment Trusts & Use Our Sector Rotation Strategy for Gains - earlytimes.in
Is BioRestorative Therapies Inc. (9OF) stock undervalued by metricsPortfolio Return Summary & High Conviction Investment Ideas - newser.com
Why BioRestorative Therapies Inc. (9OF) stock stays on top picks2025 Technical Patterns & Expert Verified Movement Alerts - newser.com
Can you recover from losses in BioRestorative Therapies Inc.Portfolio Gains Summary & Real-Time Market Trend Scan - newser.com
What analysts say about BioRestorative Therapies Inc stockStock Market Trends & Minimal Investment Capital - earlytimes.in
Published on: 2025-09-29 00:41:07 - newser.com
How hedge fund analytics apply to BioRestorative Therapies Inc. stock2025 Stock Rankings & Free Verified High Yield Trade Plans - newser.com
Published on: 2025-09-27 23:58:38 - newser.com
Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year? - sharewise.com
BioRestorative Therapies shareholders approve director elections and stock plan amendment - Investing.com Canada
BioRestorative Therapies Holds Annual Stockholders Meeting - TipRanks
BioRestorative Therapies shareholders approve director elections and stock plan amendment By Investing.com - Investing.com South Africa
Biorestorative Therapies Inc Stock (BRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):